Authors

Lauren Carcas, Miami Cancer InstituteFollow

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Publication Date

9-2020

Content Type

Article

PubMed ID:

32464281

Additional Authors:

Additional authors and institutional affiliations

Citation

Carcas, Lauren, "Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial" (2020). All Publications. 4444.
https://scholarlycommons.baptisthealth.net/se-all-publications/4444